ニュース
This phase 2b/3 trial follows new, positive 2-year data from the phase 2 ALTITUDE trial, in which sura-vec was well-tolerated ...
MUSCAT: The National Programme for Early Detection of Diabetic Retinopathy using artificial intelligence (AI) technologies ...
The agreement is for a planned clinical trial of AXPAXLI (also known as OTX-TKI) for the treatment of non-proliferative ...
21 時間
HealthDay on MSNGLP-1 Receptor Agonists May Reduce Complications of Diabetic Retinopathy
GLP-1 receptor agonists linked to modestly increased risk for incident DR, but tied to reduced risk for certain complications of DR.
New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an ...
Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the second quarter ended June 30, 2025.
Drugs such as Ozempic, Wegovy, and Mounjaro (known as semaglutide and tirzepatide) have changed the way clinicians manage ...
A new study shows drugs such as Ozempic come with a small but increased risk of a condition known as an ‘eye stroke’.
7 時間
Healthcare Asia Magazine on MSNWhat factors drive the ophthalmology surgical device market?
Eye disorders such as cataracts and glaucoma fuel the sector’s demand. The rising prevalence of vision-related disorders is ...
An Editorial in The Lancet Neurology emphasised that rigorous prospective studies are essential to develop safe and ethical artificial intelligence (AI) tools for brain health.1 Yet, what usually ...
53 分Opinion
Lohud.com, Westchester County on MSNAI Is revolutionizing healthcare in NY. Don't let government undermine progress | Opinion
Artificial intelligence is transforming healthcare — we must align government policies to support this progress. It will save ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する